卵巢组织冷冻保存用于生育力保存:适应证、原则与未来应用
综述指出抗癌治疗具性腺毒性,生育力保存应在治疗前进行;卵巢组织冷冻保存(OTC)是青春期前女孩及女性可选的唯一方法,已有约250-300例出生报告,但各中心冷冻方案差异显著,冻存组织残留病灶会阻碍生育力恢复。
要点
- OTC是青春期前女孩及女性生育力保存的唯一可选方法。
- 各生育力保存中心的冷冻保存方案存在显著差异。
- 冻存卵巢组织存在残留病灶将阻碍生育力恢复。
核心结论
- OTC是青春期前女孩及女性生育力保存的唯一方法,但方案需标准化,且冻存组织残留病灶会妨碍生育力恢复。
研究设计与样本
- 本文为综述,概述癌症及其治疗对女性生育力的影响、OTC不同操作流程及实验性生育力恢复方法。
主要发现
- 抗癌治疗具性腺毒性,建议治疗前进行生育力保存。
- OTC已有约250-300例出生报告。
- 各生育力保存中心的冷冻保存方案存在显著差异。
- 冻存卵巢片段中残留病灶将阻碍生育力恢复。
临床怎么用
- 应在开始抗癌治疗前评估并推荐生育力保存。
- 青春期前女孩及女性可考虑OTC作为生育力保存方法。
- 需关注各中心OTC方案标准化及冻存组织残留病灶评估。
局限性
- 本文为综述,未报告原始研究样本量、效应量或P值等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in cancer diagnosis and therapy have increased the 5-year survival rate. However, anticancer treatments are gonadotoxic; therefore, fertility preservation is recommended prior to the initiation of therapy to optimize future chances of conceiving. The only method for preserving fertility in prepubescent girls, also suitable for women, is ovarian tissue cryopreservation (OTC). Although approximately 250-300 births have been reported with this approach, significant variability in cryopreservation protocols is observed across fertility preservation centres. Importantly, the presence of residual disease in cryopreserved ovarian fragments will prevent the restoration of fertility. The primary aim of this review is to offer an overview of the impact of cancer and its treatment on female fertility, including the latest updates on novel therapies. This will help to refine fertility preservation indications - a growing concern in the oncofertility field. This review will also provide a comprehensive summary of the different procedures used for OTC, with the aim of standardizing protocols in clinical practice, and offer an updated overview of alternative, albeit experimental, approaches that are being developed to restore fertility and overcome the limitations of transplantation. This will highlight next-generation solutions for restoring the fertility of young female patients.
引用
- Poitrinal A, Fiot M, Dupont L, et al. Ovarian tissue cryopreservation for fertility preservation: indications, principles and future applications. Reprod Biomed Online. 2026. PMID: 42000383. doi:10.1016/j.rbmo.2026.105476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。